日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback

在接受促性腺激素释放激素激动剂诱导的卵巢抑制治疗期间,患有经前焦虑症的女性的类固醇代谢组:雌二醇和孕酮补充的影响

Nguyen, T V; Reuter, J M; Gaikwad, N W; Rotroff, D M; Kucera, H R; Motsinger-Reif, A; Smith, C P; Nieman, L K; Rubinow, D R; Kaddurah-Daouk, R; Schmidt, P J

TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics

TSPAN5、ERICH3 和选择性血清素再摄取抑制剂在重度抑郁症中的作用:基于药物代谢组学的药物基因组学研究

Gupta, M; Neavin, D; Liu, D; Biernacka, J; Hall-Flavin, D; Bobo, W V; Frye, M A; Skime, M; Jenkins, G D; Batzler, A; Kalari, K; Matson, W; Bhasin, S S; Zhu, H; Mushiroda, T; Nakamura, Y; Kubo, M; Wang, L; Kaddurah-Daouk, R; Weinshilboum, R M

Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants

难治性重度抑郁症患者对氯胺酮和艾司氯胺酮药物反应表型的代谢组学特征:快速起效抗抑郁药的新机制见解

Rotroff, D M; Corum, D G; Motsinger-Reif, A; Fiehn, O; Bottrel, N; Drevets, W C; Singh, J; Salvadore, G; Kaddurah-Daouk, R

Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine

药物反应表型的代谢组学特征:药物代谢组学助力精准医疗

Kaddurah-Daouk, R; Weinshilboum, R

Pharmacometabolomics reveals that serotonin is implicated in aspirin response variability

药物代谢组学揭示血清素与阿司匹林反应变异性有关

Ellero-Simatos, S; Lewis, J P; Georgiades, A; Yerges-Armstrong, L M; Beitelshees, A L; Horenstein, R B; Dane, A; Harms, A C; Ramaker, R; Vreeken, R J; Perry, C G; Zhu, H; Sànchez, C L; Kuhn, C; Ortel, T L; Shuldiner, A R; Hankemeier, T; Kaddurah-Daouk, R

Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo

舍曲林和安慰剂诱导的早期生化变化的药物代谢组学图谱

Kaddurah-Daouk, R; Bogdanov, M B; Wikoff, W R; Zhu, H; Boyle, S H; Churchill, E; Wang, Z; Rush, A J; Krishnan, R R; Pickering, E; Delnomdedieu, M; Fiehn, O

Alterations in metabolic pathways and networks in Alzheimer's disease

阿尔茨海默病中代谢通路和网络的改变

Kaddurah-Daouk, R; Zhu, H; Sharma, S; Bogdanov, M; Rozen, S G; Matson, W; Oki, N O; Motsinger-Reif, A A; Churchill, E; Lei, Z; Appleby, D; Kling, M A; Trojanowski, J Q; Doraiswamy, P M; Arnold, S E

Integration of pharmacometabolomic and pharmacogenomic approaches reveals novel insights into antiplatelet therapy

药物代谢组学和药物基因组学方法的整合揭示了抗血小板治疗的新见解

Lewis, J P; Yerges-Armstrong, L M; Ellero-Simatos, S; Georgiades, A; Kaddurah-Daouk, R; Hankemeier, T

Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics-informed pharmacogenomics.

嘌呤途径与阿司匹林耐药机制有关:药物代谢组学指导的药物基因组学

Yerges-Armstrong L M, Ellero-Simatos S, Georgiades A, Zhu H, Lewis J P, Horenstein R B, Beitelshees A L, Dane A, Reijmers T, Hankemeier T, Fiehn O, Shuldiner A R, Kaddurah-Daouk R

Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia

首次发作且未接受过抗精神病药物治疗的精神分裂症患者色氨酸代谢物相互作用的改变

Yao, J K; Dougherty, G G Jr; Reddy, R D; Keshavan, M S; Montrose, D M; Matson, W R; Rozen, S; Krishnan, R R; McEvoy, J; Kaddurah-Daouk, R